The U.S. enzymes market size was estimated at USD 4.36 billion in 2025 and is predicted to increase from USD 4.66 billion in 2026 to approximately USD 8.42 billion by 2035, expanding at a CAGR of 6.80% from 2026 to 2035. Due to rising demand for sustainable industrial processes, increased use in pharmaceuticals and food industries, and advancements in biotechnology companies like United Therapeutics to support innovation and online-based applications.
U.S. Enzymes Market Statical Scope
| Reports Attributes | Statistics |
| Market Size in 2025 | USD 4.36 Billion |
| Market Size in 2026 | USD 4.66 Billion |
| Market Size by 2035 | USD 8.42 Billion |
| CAGR 2026 to 2035 | 6.80% |
| Base Year | 2025 |
| Forecast Period | 2026 to 2035 |
Technological advancements are significantly transforming the US enzymes market by enabling the development of more efficient, stable, and application-specific solutions. Innovations in genetic engineering, protein modification and fermentation technologies have improved enzyme performance and have improved enzyme performance. Across industries such as pharmaceuticals, food processing, and biofuels, disadvantages allow manufacturers to reduce costs to enhance productivity and adopt more sustainable production methods.
Additionally, companies like United Therapeutics contribute to a broader innovation ecosystem by exploring the adoption of advanced enzyme technologies.
U.S. Enzymes Market Share, By Type, 2025 (%)
| Segments | Shares (%) |
| Industrial Enzymes | 55% |
| Specialty Enzymes | 45% |
- Industrial Enzymes - The segment dominated the market with a 55% share, due to its widespread use in sectors like food processing, biofuels, and detergents, whereas design-based therapies are supported by innovations. Hold a smaller portion but continue to grow steadily with increasing biomedical applications.
- Specialty Enzymes - The segment accounted for 45% of the total market share, supported by its growing use in pharmaceutical, diagnostic, and research applications, as well as continuous innovation by companies.
U.S. Enzymes Market Share, By Product, 2025 (%)
| Segments | Shares (%) |
| Carbohydrases | 44% |
| Proteases | 28% |
| Lipases | 12% |
| Polymerases & Nucleases | 9% |
| Others | 7% |
- Carbohydrases - The segment dominated the market with a 44% share, because of its extensive use in the textile industries and biofuel production. These enzymes efficiently break down complex carbohydrates into simpler sugars, improving production efficiency and product quality, which strongly drives their high demand.
- Proteases - The segment accounted for 28% of the total market share, due to its wide application in industries such as detergents, food processing, and pharmaceuticals, where it helps break down proteins and improve overall product performance.
- Lipases - The segment accounted for 12% of the total market share, driven by its growing use in food processing, detergent, and pharmaceutical applications, where it helps breakdown factor efficiency and enhance product quality and performance.
- Polymerases & Nucleases - The segment accounted for 9% of the total market share, mainly driven by their essential role in molecular biology diagnostics and genetic research, where they support DNA replication, sequencing, and advanced biotech applications.
- Others - Includes various additional conditions, with a 7% share, result in moderate contribution.
U.S. Enzymes Market Share, By Source, 2025 (%)
| Segments | Shares (%) |
| Plants | 12% |
| Animals | 7% |
| Microorganisms | 81% |
- Plants - The segment accounted for 12% of the total market share, due to the rising demand for naturally sustainable and eco-friendly enzyme sources, especially in the food, pharmaceutical, and cosmetic industries, where plant-based alternatives are increasingly preferred.
- Animals - The segment accounted for 7% of the total market share, as its use is limited by ethical concerns, regulatory restrictions, and a growing shift towards plant-based and microbial alternatives, which are considered more sustainable and widely acceptable.
- Microorganisms - The segment dominated the market with an 81% share, due to its cost-effective production, high efficiency, and scalability, while advanced biotechnological techniques continue to enhance enzymes and build stability and performance across various industrial and pharmaceutical applications.
Top Companies in the U.S. Biscuits Market
- Novozymes
- DuPont
- AB Enzyme
- BASF SE
- DSM (Koninklijke DSM N.V.)
- Amano Enzymes Inc.
- Kerry Group
- Engrain LLC
- Amano Enzyme
- AG Scientific
Segments Covered in the Report
By Type
- Industrial Enzymes
- Specialty Enzymes
By Product
- Carbohydrases
- Proteases
- Lipases
- Polymerases & Nucleases
- Others
By Source
- Plants
- Animals
- Microorganisms
| Type | 2025 | 2026 | 2027 | 2028 | 2029 | 2030 | 2031 | 2032 | 2033 | 2034 | 2035 |
|---|---|---|---|---|---|---|---|---|---|---|---|
| Industrial Enzymes | 2.35 | 2.51 | 2.66 | 2.84 | 3.02 | 3.21 | 3.42 | 3.64 | 3.87 | 4.12 | 4.42 |
| Specialty Enzymes | 2.01 | 2.15 | 2.31 | 2.47 | 2.65 | 2.85 | 3.05 | 3.28 | 3.51 | 3.76 | 4.00 |
| Source | 2025 | 2026 | 2027 | 2028 | 2029 | 2030 | 2031 | 2032 | 2033 | 2034 | 2035 |
|---|---|---|---|---|---|---|---|---|---|---|---|
| Plants | 0.70 | 0.74 | 0.78 | 0.82 | 0.87 | 0.92 | 0.96 | 1.02 | 1.07 | 1.13 | 1.18 |
| Animals | 0.52 | 0.56 | 0.59 | 0.62 | 0.66 | 0.70 | 0.74 | 0.78 | 0.83 | 0.88 | 0.97 |
| Microorganisms | 3.14 | 3.37 | 3.60 | 3.87 | 4.15 | 4.45 | 4.77 | 5.11 | 5.48 | 5.88 | 6.27 |
sales@precedenceresearch.com
+1 804-441-9344
Download Databook
Schedule a Meeting